FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Collins, Shaheen Press Insurers for Insulin Pricing Details

Dec. 4, 2018

Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) quizzed Aetna, Anthem and United Healthcare in a Nov. 20 letter on how spending on insulin has changed over the past decade.

The two co-chairs of the Senate Diabetes Caucus noted that insulin costs have increased 240 percent over that time and they asked for more information on the impact of rebates and discounts from drugmakers.

“Recent reports analyzing increasing insulin prices have noted a growing difference between a product's average list price and the net price that is ultimately received by the manufacturer,” Collins and Shaheen said.

View today's stories